5. Flashcards

1
Q

What ST depressions in anterior leads (V1-V4) can mean?

A

Either of:

  • anterior ischaemia: stable/unstable angina
  • posterior infarction: add leads V7-V9 posteriorly to confirm ST elevation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Management of stable angina

A
  • GTN spray as required (for symptomatic relief)
  • Secondary prevention: consider aspirin, statin and CV risk modification
  • one anti-anginal drug, either b-blocker or CCB
  • if still symptomatic - increase doses
  • if still symptomatic: add either of the above or long-acting nitrate (isosorbide mononitrate) or potassium channel activator (nicorandil)
  • if still uncontrolled: PCI or CABG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contraindications for b-blocker

A
  • hypotension
  • bradycardia
  • asthma
  • acute HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Contraindications for CCB

A
  • hypotension
  • bradycardia
  • peripheral oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When to add aspirin in the management of diabetes?

A

Add 75mg Aspirin in diabetic patient if:

  • over 50 years age in T2DM
  • significant CV factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When to add atorvastatin in management of diabetes?

A

20 mg Atorvastatin if:

  • significant CV risk factor
  • >50 age in T2DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ACE-inhibitor and impact on renal system

A

ACE-inhibitor in:

  • chronic setting: cardiovascular + renal protection
  • acute setting: can worsen AKI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What to do if ACR in a diabetic patient is >/3 mg/mmol?

A

add ACE-inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

1 st choice for Parkinson’s therapy?

A

Co- beneldopa or Co - Careldopa

(i.e. levodopa combined with peripheral dopa decarboxylase inhibitor: benserazide or carbidopa respectively)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

1st line therapy if a patient present with very mild Parkinson’s or concerned about a finite period of benefit from levodopa (2)

A
  • dopamine agonist: ropinirole

OR

  • monoamine oxidase (MAO) inhibitor: rasagiline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First choice of anti-epileptic for myoclonic seizures

A
  • Man: Valproate
  • Female: Levetiracetam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When epilepsy is diagnosed?

A
  • two unprovoked seizures

Or

x1 unprovoked seizure and:

  • >60% risk of recurrence in the next 10 years (abnormal MRI or EEG)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anti-epileptic treatment for tonic seizures

A
  • Male: Valproate
  • Female: Lamotrigine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment options for focal seizures

A

Carbamazepine or Lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment options for absence seizures

A

ethosuximide or valproate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment options for generalised tonic-clonic seizures

A
  • valproate for males
  • lamotrigine for females
17
Q

Medical treatment for mild dementia

A

Acetylcholinesterase (AChE) inhibitors

3 licensed drugs (but all must be started only by a specialist):

  • donepezil
  • rivastigmine
  • galantamine
18
Q

Medicine for moderate/severe dementia

A

NMDA antagonist

Memantine

19
Q

SEs of Lamotrigine

A
  • rash
  • Stevens-Johnson syndrome (rare)
20
Q

SEs of Carbamazepine

A
  • rash
  • dysarthria
  • ataxia
  • nystagmus
  • low sodium